ALB and hepatocellular carcinoma: Studies conducted by Xu et al. [26] and Toshikuni et al. [27] demonstrated that a low pre-treatment serum ALB level independently predicted worse OS in HCC patients treated with radiofrequency ablation (RFA) or percutaneous microwave ablation (PMWA).